Evolv Technologies Holdings, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
Evolv Technologies Holdings, Inc. announced a significant increase in revenue and improved Adjusted EBITDA for the second quarter of 2026, driven by strong demand for its AI-powered screening solutions.
NASDAQ
Evolv Technologies Holdings, Inc. reported a significant revenue increase in Q3 2025, driven by strong product and subscription growth, while narrowing its net loss and securing new debt financing.
NASDAQ
Evolv Technologies Holdings, Inc. reported a significantly wider net loss for the first half of 2025, driven by fair value adjustments and increased operating expenses, despite strong revenue growth and improved operating cash flow, while also detailing ongoing legal and regulatory challenges and a new $75 million credit facility.
NASDAQ
Evolv Technologies' Q1 2025 shows revenue growth driven by subscription services, while the company continues to address internal control weaknesses and legal challenges.
NASDAQ
10-Q: Evolv Technologies Restates Financials Amid Sales Practice Investigation, Reports Q3 2024 Results
Evolv Technologies restates prior financial statements due to revenue recognition errors stemming from sales practice irregularities, while also reporting a net loss for Q3 2024.
NASDAQ
Evolv Technologies Holdings saw a significant shift in revenue mix in Q2 2024, with subscription revenue doubling year-over-year, while product revenue declined sharply.
NASDAQ
Evolv Technologies' first quarter 2024 results show a 17% increase in revenue year-over-year, despite a net loss and ongoing regulatory investigations.